Guangzhou Pluslife Biotech Co., Ltd.S1.K72Guangzhou Pluslife Biotechnology Co., Ltd. was established in Guangzhou, China in 2017. We are committed to using the cutting-edge genetic technologies to develop a complete solution for independent and innovative molecular POCT diagnostic system.Pluslife has a R&D team of 40 people, of which more than 60% have Ph.D. or Master's degrees. Currently, Pluslife has applied for more than 100 patents on various technologies and holds 20 patents. Based on the self-developed isothermal molecular detection technology, Pluslife has developed Molecular POCT detection system for comprehensive application scenarios such as human respiratory infections, STD infections, genotype detection, pet disease detection, and expanded molecular detection to clinics and home-care use.